Soluble epoxide hydrolase:a next-generation drug target for Alzheimer's disease and related dementias
Andrew Gregory
Chengyun Tang
Fan Fan
Abstract:Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) represent a significant public health challenge, with projections indicating a substantial increase in affected individuals due to the aging global population. From the World Health Organization, AD/ADRD has affected more than 55 million individuals worldwide, with an additional 10 million cases diagnosed each year.
Machine-generated Keywords:
Publication Date:2025-09-27
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:2( 2585-2586 )
